Citadel Advisors - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is and the CUSIP is 48205A959. A total of 2 filers reported holding JUNO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$899,000
+22.3%
23,400
+21.2%
0.00%0.0%
Q1 2016$735,000
-21.1%
19,300
-9.0%
0.00%0.0%
Q4 2015$932,000
+39.7%
21,200
+29.3%
0.00%0.0%
Q3 2015$667,000
-91.5%
16,400
-88.8%
0.00%
-85.7%
Q2 2015$7,818,000
+426.1%
146,600
+498.4%
0.01%
+600.0%
Q1 2015$1,486,00024,5000.00%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 157,300$4,721,0000.05%
SIMPLEX TRADING, LLC 558$146,0000.01%
View complete list of JUNO THERAPEUTICS INC shareholders